Related Experiment Video
Updated: Jun 13, 2026
17:28
Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
Published on: June 17, 2015
Chemotherapy-associated hepatotoxicity: how concerned should we be?
Thomas A Aloia1, Bridget N Fahy
1Department of Surgery, The Methodist Hospital Research Institute, 6550 Fannin Street, SM1661, Houston, TX 77030, USA. taaloia@tmhs.org
Expert Review of Anticancer Therapy
|April 20, 2010
Summary
Chemotherapy may injure the liver in patients with liver cancer, but host factors like obesity also play a role. The clinical significance of this chemotherapy-associated liver injury is still being questioned.
Area of Science:
- Oncology
- Hepatology
- Pathology
Background:
- Oncosurgical strategies improve outcomes for liver colorectal cancer metastases.
- Preoperative systemic chemotherapy is increasingly used but may cause liver injury.
- Gross liver changes are noted post-chemotherapy, but histopathologic details are unclear.
Purpose of the Study:
- To review the current understanding of chemotherapy-associated liver injury.
- To determine if chemotherapy-associated liver injury impacts patient outcomes.
Main Methods:
- Literature review of studies on chemotherapy-associated liver injury.
- Analysis of host factors and their role in liver injury development.
Main Results:
- Host factors (e.g., diabetes, obesity) contribute to liver injury alongside chemotherapy.
- Limited evidence currently links chemotherapy-associated liver injury to adverse patient outcomes.
Conclusions:
- Chemotherapy-associated liver injury is a recognized entity, but its clinical significance remains debated.
- Further research is needed to clarify the impact of chemotherapy-associated liver injury on patient outcomes in hepatic colorectal cancer metastases.
Related Concept Videos
01:24Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:26Toxic Reactions: Overview
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
01:00Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...